A Phase 2 Open-Label Proof of Concept Study to Assess the Efficacy, Safety, and Pharmacokinetics of ACH-0144471 in Untreated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2017
This article has no abstract
Epistemonikos ID: 132aa0b7a51e29e3e567cecddfa13e24db369b5d
First added on: Jan 23, 2025